The Efficacy and Safety of Neoadjuvant Toripalimab Combined With Temozolomide in Resectable Stage III Melanoma: A Prospective, Single-center, Phase 2 Clinical Trial
Latest Information Update: 27 Apr 2023
At a glance
- Drugs Temozolomide (Primary) ; Toripalimab (Primary)
- Indications Malignant melanoma
- Focus Therapeutic Use
Most Recent Events
- 27 Apr 2023 New trial record